SEC Form 4 reporting owner

Azamian Bobak R.

Azamian Bobak R. has filed 18 Form 4 transactions reported between December 4, 2025 and September 4, 2026, as President/CEO and Board Chair of Tarsus Pharmaceuticals, Inc..

Name as filed: Azamian Bobak R.

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$5.2M
10 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 4, 2026
transaction date

Roles and reported holdings

  • TARSTarsus Pharmaceuticals, Inc.
    Dec 4, 2025 – Sep 4, 2026

    President/CEO and Board Chair

    Held directly33,421 sh as of Mar 19, 2026 · Form 4
    Held indirectly (latest line)827,991 sh as of Sep 4, 2026 · Form 4

    24 months: $5.2M sold

Transaction history

All 18 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 4, 2026TARSPresident/CEO and Board ChairOpen-market saleCode S · indirect2,900$265K@ $91.27Form 4
Sep 4, 2026TARSPresident/CEO and Board ChairOpen-market saleCode S · indirect7,100$641K@ $90.27Form 4
Sep 2, 2026TARSPresident/CEO and Board ChairOpen-market saleCode S · indirect10,000$801K@ $80.06Form 4
Jun 17, 2026TARSPresident/CEO and Board ChairOpen-market saleCode S · indirect5,418$335K@ $61.81Form 4
Jun 17, 2026TARSPresident/CEO and Board ChairOpen-market saleCode S · indirect4,582$281K@ $61.24Form 4
Mar 19, 2026TARSPresident/CEO and Board ChairOpen-market saleCode S · direct11,964$802K@ $67.00Form 4
Mar 18, 2026TARSPresident/CEO and Board ChairOpen-market saleCode S · direct11,667$802K@ $68.71Form 4
Mar 17, 2026TARSPresident/CEO and Board ChairOpen-market saleCode S · direct10,972$762K@ $69.42Form 4
Mar 15, 2026TARSPresident/CEO and Board ChairOption exerciseCode M · direct14,878—Form 4
Mar 15, 2026TARSPresident/CEO and Board ChairOption exerciseCode M · direct23,121—Form 4
Mar 15, 2026TARSPresident/CEO and Board ChairOption exerciseCode M · direct16,975—Form 4
Mar 15, 2026TARSPresident/CEO and Board ChairOption exerciseCode M · direct11,300—Form 4
Mar 15, 2026TARSPresident/CEO and Board ChairOption exerciseCode M · direct66,274—Form 4
Mar 5, 2026TARSPresident/CEO and Board ChairGrant or awardCode A · direct60,776—Form 4
Mar 5, 2026TARSPresident/CEO and Board ChairGrant or awardCode A · direct96,723—Form 4
Dec 24, 2025TARSPresident/CEO and Board ChairOpen-market saleCode S · indirect557$47K@ $83.54Form 4
Dec 24, 2025TARSPresident/CEO and Board ChairOpen-market saleCode S · indirect5,443$449K@ $82.41Form 4
Dec 4, 2025TARSPresident/CEO and Board ChairGiftCode G · direct51,885—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.